ABSTRACTS

You can prepare your abstract(s) in your ONLINE ACCOUNT section and edit them until you submit your abstract(s) for review by the Scientific Committee.

Please read the abstract guidelines carefully:

Abstract Submission Starts15 October 2018
Abstract Submission Ends15 January 2019
The announcement of Accepted Abstracts15 March 2019
Registration Deadline for Authors of Accepted Abstracts, under the early bird registration fee25 March 2019
Announcement of Final Program15 April 2019

IMPORTANT

Authors can submit abstracts for oral presentation or e-poster for the 5th European Congress for Bronchology and Interventional Pulmonology.

All abstracts must be prepared in English only.

Abstracts will be accepted only through the “Online Abstract System” on our website by January 15, 2019.

Abstracts sent through e-mail, fax, ordinary post or delivered by hand will not be evaluated.

Please carefully check all text for errors before submitting through the system as the quality of your submission may strongly affect the scoring of your abstract by the referees.

ABSTRACT TOPICS

  • Pneumothorax
  • Malignant pleural effusion
  • Infections of pleura
  • Pleura miscellaneous
  • Diagnostic bronchoscopy
  • Solitary pulmonary nodules – diagnostics
  • Solitary pulmonary nodules – therapy
  • Lung cancer diagnosis and staging
  • Interstitial lung diseases diagnosis
  • Cryotechnique for diagnosis and therapy
  • Benign obstruction of central airways
  • Malignant obstruction of central airways
  • Emphysema treatment
  • Treatment of obstructive diseases
  • Pulmonary infections – approach and treatment
  • Ultrasound in interventional pulmonology
  • Education and training
  • Miscellaneous

ABSTRACT SUBMISSION GUIDELINES

Online Abstract System Procedure

  • Authors must first open an account on the online abstract system with a username and password.
  • Please do not forget to authorize your abstract as COMPLETED once submitted. Only authorized abstracts will be evaluated. Abstracts not authorized by the authors will not be submitted to referees.

Abstract Submission Rules

  • Abstract should not be longer than 250 words.
  • Abstract title must be less than 10 words and express the essence of the research.
  • Name, last name, title, institution, city and contact details of authors must be stated clearly.
  • Presenting author must be stated in the system.
  • Abstract body should not include any indication of the authors’ personal details.
  • Avoid reference to institution names, locations, or funding sources within the text of the abstract.
  • Abstract (except for case reports)  should be divided into sections as below:
    Aim or purpose
     :In one brief sentence, provide the rationale for the investigation and/or the question to be answered, with or without short citation(s). Citations should be listed and provide the name and initials of authors (max. 3), title of article, title of journal, year of publication, the volume number and first and last page numbers in full. Please note: the aim implies that case reports cannot be accepted, unless the findings lead to more general statements.
    Materials and methods
    : The experimental conditions should be reported briefly (i.e. age group, features of the subjects, gender, etc.). The clinical approach and the study period should be clearly stated. The methods used should also be briefly and clearly explained (i.e. image analysis, biochemical data, histological, immunohistological or molecular analysis of the data, statistical significance). 
    Results: The most significant findings should be stated briefly. 
    Conclusions:
     This final statement is crucial because it supports the scientific value of the presentation
  • Abstracts of the unfinished researches will not be evaluated.
  • Tables, charts or graphics should not be included in the abstracts.
  • Please avoid submitting abstracts already submitted elsewhere or presented previously.

Evaluation Criteria
The evaluation by the reviewers is based on scientific or clinical interest in the topic assessed, sufficiency of provided data, innovation and clinical impact.

Announcement of Accepted Abstracts

  • Abstract acceptance letters will be sent by March 15, 2019 to the submitting authors contact e-mail address in the system.
  • At least 1 of the authors of each accepted abstract have to register before March 25th, 2019, in order to include their abstract in the final scientific program.

Oral Presentation:
Only Power Point presentations will be allowed. Be sure to bring your presentation on a USB drive.

The use of personal lap-tops is not allowed. 

The time allocated for oral presentations will be 7 minutes + 3 minutes of discussion. Material for presentation should be uploaded in the Preview Room at least 2 hours before the presentation. We encourage you to check your presentation in the Preview Room well in advance.

E-Posters 
At the ECBIP 2019, we will be using e-posters instead of conventional printed posters. We are using e-posters to reduce carbon footprint and to save on the costs associated with printing and laminating a conventional poster.

What is an E-Poster? 
An e-poster is an electronic version of the traditional boards, and is displayed on monitor screens. The e-poster may include text, figures and images, as well as video.

When can I view a specific poster? 
A specific poster can be viewed any time during the Congress. A specific time slot will not be required. Simply use one of the computers located in the e-poster area at a time convenient to you. You will be able to view all electronic posters as frequently, and as often as you wish.

Following Submission
You will receive more information about submitting the e-poster, registration CODE for early bird and additional information by email. For assistance, please contact the technical organizer.